Publications by authors named "T Cluzeau"

Claim this Profile
P
Predicting the toxicity-efficacy ratio of venetoclax in real-world patients.
Loïc Osanno, Lucy Brocque, Laurent Bourguignon, Carla Delpech, Laure Farnault, Thomas Cluzeau

Ann Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid neoplasms risks for germline DDX41 pathogenic variants carriers.
Marie-Charlotte Villy, Youenn Drouet, Lise Larcher, Yoann Vial, Benjamin Dauriat, Thomas Cluzeau

Eur J Hum Genet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplantation in lower risk MDS patients: a prospective phase 2 trial based on donor availability.
Marie Sebert, Sylvain Thepot, Thomas Cluzeau, Nicolas Duployez, Thibaud Lefebvre

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-adapted chemotherapy and MRD-oriented transplant for Ph-negative acute lymphoblastic leukemia: the GRAALL-2014 trial.
Nicolas Boissel, Sylvie Chevret, Françoise Rigal-Huguet, Thibaut Tl Leguay, Mathilde Hunault, Thomas Cluzeau

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real World Experience of Azacitidine + Venetoclax in Acute Myeloid Leukemia Rigorously Following Management Guidelines from Clinical Trial.
Bochra Sedaki, Alexandre Iat, Sami Benachour, Michael Loschi, Karine Risso, Thomas Cluzeau

Acta Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis